162 related articles for article (PubMed ID: 35326640)
81. NF-kappaB inducing kinase activates NF-kappaB transcriptional activity independently of IkappaB kinase gamma through a p38 MAPK-dependent RelA phosphorylation pathway.
Jijon H; Allard B; Jobin C
Cell Signal; 2004 Sep; 16(9):1023-32. PubMed ID: 15212763
[TBL] [Abstract][Full Text] [Related]
82. BYHWD Alleviates Inflammatory Response by NIK-Mediated Repression of the Noncanonical NF-κB Pathway During ICH Recovery.
Xiao W; He Z; Luo W; Feng D; Wang Y; Tang T; Yang A; Luo J
Front Pharmacol; 2021; 12():632407. PubMed ID: 34025405
[TBL] [Abstract][Full Text] [Related]
83. Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling.
Saldanha-Araujo F; Haddad R; Farias KC; Souza Ade P; Palma PV; Araujo AG; Orellana MD; Voltarelli JC; Covas DT; Zago MA; Panepucci RA
J Cell Mol Med; 2012 Jun; 16(6):1232-44. PubMed ID: 21777379
[TBL] [Abstract][Full Text] [Related]
84. NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes.
Xiao P; Takiishi T; Violato NM; Licata G; Dotta F; Sebastiani G; Marselli L; Singh SP; Sze M; Van Loo G; Dejardin E; Gurzov EN; Cardozo AK
Cell Death Dis; 2022 May; 13(5):476. PubMed ID: 35589698
[TBL] [Abstract][Full Text] [Related]
85. TNFR2 ligation in human T regulatory cells enhances IL2-induced cell proliferation through the non-canonical NF-κB pathway.
Wang J; Ferreira R; Lu W; Farrow S; Downes K; Jermutus L; Minter R; Al-Lamki RS; Pober JS; Bradley JR
Sci Rep; 2018 Aug; 8(1):12079. PubMed ID: 30104686
[TBL] [Abstract][Full Text] [Related]
86. OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3.
Zhang B; Yang C; Wang R; Wu J; Zhang Y; Liu D; Sun X; Li X; Ren H; Qin S
J Exp Clin Cancer Res; 2020 Nov; 39(1):244. PubMed ID: 33198776
[TBL] [Abstract][Full Text] [Related]
87. BMP-7 represses albumin-induced chemokine synthesis in kidney tubular epithelial cells through destabilization of NF-κB-inducing kinase.
Lim AI; Chan LY; Tang SC; Yiu WH; Li R; Lai KN; Leung JC
Immunol Cell Biol; 2014; 92(5):427-35. PubMed ID: 24418819
[TBL] [Abstract][Full Text] [Related]
88. BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells.
Chiou JT; Lee YC; Wang LJ; Chang LS
Chem Biol Interact; 2022 Jul; 361():109978. PubMed ID: 35561756
[TBL] [Abstract][Full Text] [Related]
89. NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis.
Boutaffala L; Bertrand MJ; Remouchamps C; Seleznik G; Reisinger F; Janas M; Bénézech C; Fernandes MT; Marchetti S; Mair F; Ganeff C; Hupalowska A; Ricci JE; Becher B; Piette J; Knolle P; Caamano J; Vandenabeele P; Heikenwalder M; Dejardin E
Cell Death Differ; 2015 Dec; 22(12):2020-33. PubMed ID: 26045047
[TBL] [Abstract][Full Text] [Related]
90. Chalepin: A Compound from
Richardson JSM; Aminudin N; Abd Malek SN
Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S489-S498. PubMed ID: 29142404
[TBL] [Abstract][Full Text] [Related]
91. Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells.
Hideshima T; Ikeda H; Chauhan D; Okawa Y; Raje N; Podar K; Mitsiades C; Munshi NC; Richardson PG; Carrasco RD; Anderson KC
Blood; 2009 Jul; 114(5):1046-52. PubMed ID: 19436050
[TBL] [Abstract][Full Text] [Related]
92. Activation of the non-canonical NF-κB/p52 pathway in vascular endothelial cells by RANKL elicits pro-calcific signalling in co-cultured smooth muscle cells.
Harper E; Rochfort KD; Forde H; Davenport C; Smith D; Cummins PM
Cell Signal; 2018 Jul; 47():142-150. PubMed ID: 29678621
[TBL] [Abstract][Full Text] [Related]
93. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.
Momeny M; Zakidizaji M; Ghasemi R; Dehpour AR; Rahimi-Balaei M; Abdolazimi Y; Ghavamzadeh A; Alimoghaddam K; Ghaffari SH
Med Oncol; 2010 Sep; 27(3):833-42. PubMed ID: 19763917
[TBL] [Abstract][Full Text] [Related]
94. p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κB.
Tatangelo V; Boncompagni G; Capitani N; Lopresti L; Manganaro N; Frezzato F; Visentin A; Trentin L; Baldari CT; Patrussi L
Front Oncol; 2022; 12():877495. PubMed ID: 35847884
[TBL] [Abstract][Full Text] [Related]
95. Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia.
Burley TA; Hesketh A; Bucca G; Kennedy E; Ladikou EE; Towler BP; Mitchell S; Smith CP; Fegan C; Johnston R; Pepper A; Pepper C
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406371
[TBL] [Abstract][Full Text] [Related]
96.
Pippione AC; Sainas S; Federico A; Lupino E; Piccinini M; Kubbutat M; Contreras JM; Morice C; Barge A; Ducime A; Boschi D; Al-Karadaghi S; Lolli ML
Medchemcomm; 2018 Jun; 9(6):963-968. PubMed ID: 30108985
[TBL] [Abstract][Full Text] [Related]
97. NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma.
Jayawant E; Pack A; Clark H; Kennedy E; Ghodke A; Jones J; Pepper C; Pepper A; Mitchell S
Front Oncol; 2023; 13():1181660. PubMed ID: 37333821
[TBL] [Abstract][Full Text] [Related]
98. NF-kB and the CLL microenvironment.
O'Donnell A; Pepper C; Mitchell S; Pepper A
Front Oncol; 2023; 13():1169397. PubMed ID: 37064123
[TBL] [Abstract][Full Text] [Related]
99. B cell receptor signaling and associated pathways in the pathogenesis of chronic lymphocytic leukemia.
Schmid VK; Hobeika E
Front Oncol; 2024; 14():1339620. PubMed ID: 38469232
[TBL] [Abstract][Full Text] [Related]
100. The NFκB signaling system in the generation of B-cell subsets: from germinal center B cells to memory B cells and plasma cells.
Roy K; Chakraborty M; Kumar A; Manna AK; Roy NS
Front Immunol; 2023; 14():1185597. PubMed ID: 38169968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
